Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 18/20 | 0.59 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | F11 | P03951 | 1/20 | 0.40 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
| ▸ | F7 | P08709 | 1/20 | 0.40 |
| ▸ | TPSB2 | P20231 | 1/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.34 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21437517 | 0.95 | CFD (0.65) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21437990 | 0.94 | CFD (0.60) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21437710 | 0.94 | CFD (0.61) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21437432 | 0.93 | CFD (0.62) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21438363 | 0.91 | CFD (0.64) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21438841 | 0.90 | CFD (0.62) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL23217630 | 0.89 | CFD (0.73) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21438480 | 0.89 | CFD (0.61) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21437301 | 0.89 | CFD (0.63) | CFDPLGPLAUF11KLKB1 | |
| SCHEMBL21437984 | 0.89 | CFD (0.63) | CFDPLGPLAUF11KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021072156-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-04-15 | — | — | WO | disclosed |